The cost associated with publishing research findings in ACS Pharmacology & Translational Science represents a mandatory charge levied upon authors whose manuscripts are accepted for publication. This fee contributes to covering the expenses related to peer review, editorial services, online hosting, and the dissemination of scholarly work to a broad audience. For instance, authors of a research article focused on novel drug targets in oncology would typically be required to pay this charge after the successful completion of the peer-review process and acceptance of their manuscript.
This funding mechanism ensures the journal’s sustainability and open accessibility, allowing researchers worldwide to access cutting-edge advancements in pharmacology and translational science. The implementation of article processing charges (APCs), such as this one, is a growing trend in academic publishing, facilitating open access models and increasing the impact of published research. It allows for immediate and unrestricted access to scientific findings, fostering collaboration and accelerating scientific progress by removing paywalls.
